Form4insider filings, from the source

SEC Form 4 · accession 0000899243-18-020446

CONSTELLATION PHARMACEUTICALS INC · CNST

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Tim Kutzkey
10% Owner
Period of report
Jul 23, 2018
Accepted (ET)
Jul 23, 2018 · 8:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001434418

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2,F3,F4,F5Jul 23, 2018C4,666,888—A4,677,939D
Common StockF1,F6Jul 23, 2018C79,155—A79,155ISee footnote

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Series A Preferred StockF3,F1—Jul 23, 2018C11,000,000D——Common Stock999,1800D
Series B Preferred StockF3,F1—Jul 23, 2018C8,333,333D——Common Stock756,9550D
Series D Preferred StockF3,F1—Jul 23, 2018C970,159D——Common Stock88,1240D
Series E Preferred StockF3,F1—Jul 23, 2018C3,555,555D——Common Stock415,2440D
Series E Preferred StockF6,F1—Jul 23, 2018C444,444D——Common Stock51,9050I
Series E-1 Preferred StockF7,F8,F1—Jul 23, 2018C6,502,856D——Common Stock590,6890D
Series F Preferred StockF9,F10,F1—Jul 23, 2018C20,000,000D——Common Stock1,816,6960D
Series F Preferred StockF6,F1—Jul 23, 2018C300,000D——Common Stock27,2500I

Explanation of responses